Joel Claveau
Quebec, QC G1R3S1, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Guidelines for Clinicians and Pathologists on Performing Skin Biopsies and Reporting on Suspected Cutaneous Squamous Cell Carcinoma.
Journal: Current oncology (Toronto, Ont.)
Published: September 30, 2025
CaSMO Recommendations for Prevention and Treatment of Cutaneous Adverse Events Related to Cancer Therapies in Darker Skin Phototypes.
Journal: Clinical, cosmetic and investigational dermatology
Published: May 21, 2025
Systemic treatment of immune checkpoint inhibitor-induced psoriasis: Inference-based guidance.
Journal: Journal of the European Academy of Dermatology and Venereology : JEADV
Published: February 04, 2025
Modified Delphi Consensus on Interventions for Acute Radiation Dermatitis in Breast Cancer: A Canadian Expert Perspective.
Journal: International journal of radiation oncology, biology, physics
Published: October 18, 2024
A case of eruptive xanthomas associated with pregnancy unmasking a G188E heterozygous mutation of the lipoprotein lipase gene: A case report.
Journal: SAGE open medical case reports
Published: October 24, 2022
Population-Based Study Detailing Cutaneous Melanoma Incidence and Mortality Trends in Canada.
Journal: Frontiers in medicine
Published: December 06, 2021
Analysis of Geographic and Environmental Factors and Their Association with Cutaneous Melanoma Incidence in Canada.
Journal: Dermatology (Basel, Switzerland)
Published: November 25, 2021
Reflex Molecular Testing in Melanoma Diagnosis: When Should BRAF Mutation Testing Be Ordered and Who Should Order It?
Journal: Journal of cutaneous medicine and surgery
Published: September 08, 2021
Multicenter, double-blind, placebo-controlled trial of seviprotimut-L polyvalent melanoma vaccine in patients with post-resection melanoma at high risk of recurrence.
Journal: Journal for immunotherapy of cancer
Published: September 06, 2021
Management of Pyrexia Associated with the Combination of Dabrafenib and Trametinib: Canadian Consensus Statements.
Journal: Current oncology (Toronto, Ont.)
Published: July 30, 2021
Last Updated: 09/26/2026